Expert Opinion on Drug Discovery, Volume 15, Issue 11 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Discovery, Volume 15, Issue 11 (2020)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Vol 16, 2021 Volume 15, 2020 Vol 14, 2019 Vol 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
Mohamed Boudjelal, Atef Nehdi & Imadul Islam
Pages: 1233-1235
Published online: 16 Jun 2020
First Page PreviewforWhy do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited! | Full Text | References | PDF (318.5 KB) | EPUB
  • 22811 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Editorial
How effective are nonalcoholic fatty liver disease models for drug discovery?
Jana Hundertmark & Frank Tacke
Pages: 1237-1240
Published online: 11 Jun 2020
AbstractforHow effective are nonalcoholic fatty liver disease models for drug discovery? | Full Text | References | PDF (238.1 KB) | EPUB
  • 3283 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?
Bruno Pietro Imbimbo, Stefania Ippati & Mark Watling
Pages: 1241-1251
Published online: 20 Jul 2020
AbstractforShould drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere? | Full Text | References | PDF (1.5 MB) | EPUB
  • 412 Views
  • 13 CrossRef citations
  • 0Altmetric
What is on the horizon for type 2 diabetes pharmacotherapy? – An overview of the antidiabetic drug development pipeline
Karl Sebastian Johansson, David Peick Sonne, Filip Krag Knop & Mikkel Bring Christensen
Pages: 1253-1265
Published online: 09 Jul 2020
AbstractforWhat is on the horizon for type 2 diabetes pharmacotherapy? – An overview of the antidiabetic drug development pipeline | Full Text | References | PDF (817.4 KB) | EPUB
  • 802 Views
  • 5 CrossRef citations
  • 0Altmetric

Review

The combination of artificial intelligence and systems biology for intelligent vaccine design
Giulia Russo, Pedro Reche, Marzio Pennisi & Francesco Pappalardo
Pages: 1267-1281
Published online: 14 Jul 2020
AbstractforThe combination of artificial intelligence and systems biology for intelligent vaccine design | Full Text | References | PDF (2.9 MB) | EPUB
  • 3291 Views
  • 24 CrossRef citations
  • 0Altmetric
Explaining biosimilars and how reverse engineering plays a critical role in their development
Salvatore Bellinvia & Christopher J. Edwards
Pages: 1283-1289
Published online: 27 Jul 2020
AbstractforExplaining biosimilars and how reverse engineering plays a critical role in their development | Full Text | References | PDF (326.6 KB) | EPUB
  • 222 Views
  • 4 CrossRef citations
  • 0Altmetric
Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions
Andrey D. Bondarev, Misty M. Attwood, Jörgen Jonsson, Vladimir N. Chubarev, Vadim V. Tarasov & Helgi B. Schiöth
Pages: 1291-1307
Published online: 10 Jul 2020
AbstractforOpportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions | Full Text | References | PDF (3 MB) | EPUB
  • 7616 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access
Drug discovery strategies for modulating oxidative stress in gastrointestinal disorders
Taraneh Mousavi, Nastaran Hadizadeh, Shekoufeh Nikfar & Mohammad Abdollahi
Pages: 1309-1341
Published online: 04 Aug 2020
AbstractforDrug discovery strategies for modulating oxidative stress in gastrointestinal disorders | Full Text | References | PDF (3.2 MB) | EPUB
  • 202 Views
  • 16 CrossRef citations
  • 0Altmetric
Antimicrobial peptides: a promising strategy for lung cancer drug discovery?
Farshid Zandsalimi, Sam Talaei, Mehdi Noormohammad Ahari, Shahin Aghamiri, Pourya Raee, Soheil Roshanzamiri, Fatemeh Yarian, Mojgan Bandehpour & Zeinab Zohrab Zadeh
Pages: 1343-1354
Published online: 04 Aug 2020
AbstractforAntimicrobial peptides: a promising strategy for lung cancer drug discovery? | Full Text | References | PDF (3.2 MB) | EPUB
  • 375 Views
  • 16 CrossRef citations
  • 0Altmetric
Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?
Slobodan M. Janković & Snežana V. Janković
Pages: 1355-1364
Published online: 20 Jul 2020
AbstractforLessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts? | Full Text | References | PDF (855.1 KB) | EPUB
  • 257 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov et al.
Review Article | Published online: 28 Jul 2024
Open Access
Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
Imane Charmarke-Askar et al.
Review Article | Published online: 22 Jul 2024
What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
View all latest articles